Novel unimolecular combination models for selective tumour targeting: A tandem approach to the enhancement of chemoselectivity and abrogation of chemoresistance

用于选择性肿瘤靶向的新型单分子组合模型：增强化学选择性和消除化学耐药性的串联方法

• 批准号: 281400
• 负责人: Jean-Claude Bertrand J
• 金额: $ 22.69万
• 依托单位: Research Institute of the McGill University Health Centre
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-03-01 至 2016-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=281400&lang=en
• 关键词: Breast; Egf; Egfr; Her1; Her2; Ovarian

Cancer cells are protected by several proteins that prevent them from dying. These proteins allow them to communicate with the body and particularly to receive message telling them to multiply. Cells that are normal, receive a message to stop multiplying

癌细胞受到几种蛋白质的保护，防止它们死亡。这些蛋白质使它们能够与身体沟通，特别是接收信息，告诉它们繁殖。正常的细胞会收到停止增殖的信息